Poster
Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia in Europe, a Real-World Perspective
Nov 13, 2018
Download
To date, there are no robust head-to-head comparisons of tyrosine kinase inhibitors (TKIs) regarding treatment flow in chronic myeloid leukaemia (CML). The available evidence is limited to observational studies of small size. This study aims to understand treatment patterns of TKIs and relevant side effects in CML
Contact Us